These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 15566417)

  • 1. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.
    Appenzeller S; Costallat LT
    Cephalalgia; 2004 Dec; 24(12):1024-30. PubMed ID: 15566416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic and psychological features of headache in systemic lupus erythematosus.
    Omdal R; Waterloo K; Koldingsnes W; Husby G; Mellgren SI
    J Rheumatol; 2001 Apr; 28(4):772-9. PubMed ID: 11327249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
    Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
    Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Zonana-Nacach A; Santana-Sahagún E; Jiménez-Balderas FJ; Camargo-Coronel A
    J Clin Rheumatol; 2008 Apr; 14(2):74-7. PubMed ID: 18391674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
    Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
    Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgG-type antihistone antibodies. Diagnostic value in rheumatoid polyarthritis, scleroderma, spontaneous and drug-induced lupus].
    Meyer O; Cyna L; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Jun; 51(6):303-10. PubMed ID: 6382565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus.
    Bernatsky S; Pineau CA; Lee JL; Clarke AE
    Lupus; 2006; 15(10):671-4. PubMed ID: 17120594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.
    Amezcua-Guerra LM; Springall R; Marquez-Velasco R; Gómez-García L; Vargas A; Bojalil R
    Arthritis Res Ther; 2006; 8(5):R144. PubMed ID: 16934155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus.
    Gould T; Tikly M; Asherson R; Loizou S; Singh S
    Scand J Rheumatol; 2006; 35(1):29-34. PubMed ID: 16467038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
    Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinucleosome antibodies and systemic lupus erythematosus.
    Düzgün N; Sahin M; Genç Y; Tutkak H
    Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus.
    Rensch MJ; Szyjkowski R; Shaffer RT; Fink S; Kopecky C; Grissmer L; Enzenhauer R; Kadakia S
    Am J Gastroenterol; 2001 Apr; 96(4):1113-5. PubMed ID: 11316156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus: a clinical and immunological study of 300 patients].
    Font J; Pallarés L; Cervera R; Vivancos J; López-Soto A; Herrero C; Darnell A; Torras A; Mirapeix E; del Olmo JA
    Med Clin (Barc); 1993 Apr; 100(16):601-5. PubMed ID: 8497156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.